Aerolase Neo Elite
Nd:YAG laser (microsecond) · 1064nm 650-microsecond, higher energy
What it's actually cleared for: The Aerolase 1064nm family cleared under K120235 (September 2012) for dermatologic indications including vascular and pigmented lesions, wrinkles, acne, and hair removal in all skin types — verifiable on accessdata.fda.gov. "Neo Elite" is a trade name within that cleared family; confirm current labeling before quoting indications in ads.
Last verified: August 6, 2026 · How we verify
New: $65k–$90k|Used: $35k–$55kmarket estimate, no email required
Bottom line
The rare laser that earns its keep in a solo-operator medspa: one 1064nm workhorse with zero consumables, a 22-lb footprint, and legitimate safety across all six Fitzpatrick types. It won't out-punch a dedicated IPL for diffuse redness or a diode bank for high-volume hair removal, but as a first or second device it covers acne, redness, pigment, and revitalization with almost no downtime and no per-treatment cost. The catch: results are technique- and protocol-dependent — undertrained operators get "meh" outcomes that stall rebooking. Buy it if your base skews skin of color or acne.
Overview
Pain-tolerant all-skin-type HR/skin device
How it works
The science
Single-wavelength 1064nm Nd:YAG delivering energy in a 650-microsecond pulse — shorter than the thermal relaxation time of melanin-rich epidermis, so heat deposits in targets (hemoglobin, melanin, sebaceous activity, water) before it can diffuse and injure surrounding skin. That's why it runs without contact cooling, gel, or chillers and stays safe on Fitzpatrick IV-VI. Used for inflammatory acne (NeoClear), rosacea and redness, PIH and benign pigment, hair reduction, PFB, onychomycosis, warts, and NeoSkin revitalization passes.
Patented tech
"650 Microsecond Technology" — a proprietary compact laser head firing unusually short free-running Nd:YAG pulses at high peak power; the pulse duration, not a new wavelength, is the entire differentiator.
Origin
USA (Tarrytown, New York).
FDA & regulatory status
What it's actually cleared for:
The Aerolase 1064nm family cleared under K120235 (September 2012) for dermatologic indications including vascular and pigmented lesions, wrinkles, acne, and hair removal in all skin types — verifiable on accessdata.fda.gov. "Neo Elite" is a trade name within that cleared family; confirm current labeling before quoting indications in ads.
Regulatory data is compiled from public FDA 510(k) records and may lag recent clearances. Always confirm status with the manufacturer before purchase.
Treatment economics
What practices charge
~$250-600 per NeoSkin session, $200-400 per NeoClear acne session — acne sold as 4-6 session courses ($1,000-2,000) since singles underdeliver. Hair removal $100-400 per area. Memberships work well with no consumable drag.
Consumables & recurring cost
Effectively zero — no tips, no gel, no cryogen, air-cooled. A few hundred dollars/year in distance gauges and optics at most — the strongest line in the whole pro-forma.
Ideal for
Best-fit practice
Injector-led or NP-owned medspas adding a first energy device, especially in skin-of-color markets or with a teen/young-adult acne pipeline competitors' IPLs can't safely serve. Wrong fit for practices whose thesis is body hair removal at volume.
Compliance
Medical director & delegation
Class IV laser (FDA Class II device); most states require physician/mid-level oversight with delegation to RNs (some states laser techs/aestheticians) under protocol.
Contraindications & screening
Pregnancy, recent isotretinoin (policy varies), photosensitizers, active infection or open lesions, recent significant tanning, gold therapy, unrealistic melasma expectations.
Ownership
Warranty & service
Typically 2 years manufacturer warranty with US-based service and a reputation for responsiveness; out-of-warranty repairs less punishing than flashlamp platforms.
Resale & used market
Genuinely liquid — clean Neo Elites move at $30k-50k, faster than most single-wavelength devices thanks to injector brand awareness; values stable.
Chains using this device
No confirmed chain deployments recorded yet.
Owner reviews
Write a reviewNo approved reviews yet. Be the first owner to publish one.
Alternatives
History
Every tracked change to pricing, lifecycle status, FDA data and warranty terms — newest first.
August 1, 2026
Record created
Added to The Aesthetic Index — August 2026
Source: The Aesthetic Index editorial
Get the full State of Aesthetic Devices 2026 report
The first independent census of the US aesthetic device market — free.